why choose us

Course: Management of Heart Failure

CME Credits: 1.00

Released: 2022-09-15

Since the 2017 publication of the ACC/AHA/HFSA focused update of HF guidelines, multiple clinical trials have demonstrated the significant benefits of novel medical therapies for patients with HF across the spectrum of EF.- The emergence of these therapies adds nuance and complexity to the care of patients with HF.


To identify the key insights or developments described in this article


View Full Course